Kidswell Bio Corporation (TYO:4584)
274.00
+9.00 (3.40%)
At close: Mar 6, 2026
Kidswell Bio Revenue
Kidswell Bio had revenue of 1.74B JPY in the quarter ending December 31, 2025, with 35.40% growth. This brings the company's revenue in the last twelve months to 7.06B, up 276.40% year-over-year. In the fiscal year ending March 31, 2025, Kidswell Bio had annual revenue of 5.08B with 223.90% growth.
Revenue (ttm)
7.06B
Revenue Growth
+276.40%
P/S Ratio
1.92
Revenue / Employee
190.93M
Employees
37
Market Cap
13.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.08B | 3.51B | 223.90% |
| Mar 31, 2022 | 1.57B | 573.00M | 57.53% |
| Mar 31, 2021 | 996.00M | -81.00M | -7.52% |
| Mar 31, 2020 | 1.08B | 55.30M | 5.41% |
| Mar 31, 2019 | 1.02B | -38.02M | -3.59% |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| StemCell Institute | 2.78B |
| ReproCELL | 2.52B |
| Immuno-Biological Laboratories | 1.03B |
| Stella Pharma | 968.00M |
| CellSeed | 161.00M |
| Nano Holdings | 155.00M |
| Kubota Pharmaceutical Holdings | 21.34M |
| BrightPath Biotherapeutics | 1.11M |